We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.66B
2
HCA icon
HCA Healthcare
HCA
+$1.02B
3
BNY
Bank of New York Mellon
BNY
+$949M
4
AMT icon
American Tower
AMT
+$931M
5
FRC
First Republic Bank
FRC
+$890M

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYHHZ
2551
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
73,700
– –
ACRS icon
2552
Aclaris Therapeutics
ACRS
$871M
– –
-340,343
Closed -$8.78M
ACWX icon
2553
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
– –
-93,026
Closed -$4.5M
ALCO icon
2554
Alico
ALCO
$307M
– –
-7,310
Closed -$250K
OSG
2555
Octave Specialty Group
OSG
$205M
– –
-23,926
Closed -$413K
APVO icon
2556
Aptevo Therapeutics
APVO
$5.16M
– –
0
– -$47K
ARDX icon
2557
Ardelyx
ARDX
$982M
– –
-912,401
Closed -$5.11M
ASTC icon
2558
Astrotech Corp
ASTC
$18.9M
– –
-259
Closed -$38K
BCRX icon
2559
BioCryst Pharmaceuticals
BCRX
$2.64B
– –
-27,923
Closed -$146K
BSET icon
2560
Bassett Furniture
BSET
$170M
– –
-11,130
Closed -$420K
CARM
2561
DELISTED
Carisma Therapeutics
CARM
– –
-2,635
Closed -$83K
CECO icon
2562
Ceco Environmental
CECO
$4.32B
– –
-17,481
Closed -$148K
CRK icon
2563
Comstock Resources
CRK
$4.23B
– –
-920,313
Closed -$5.6M
CRSP icon
2564
CRISPR Therapeutics
CRSP
$5.23B
– –
-151,510
Closed -$2.71M
EHTH icon
2565
eHealth
EHTH
$39.1M
– –
-8,844
Closed -$211K
ETD icon
2566
Ethan Allen Interiors
ETD
$602M
– –
-399,710
Closed -$13M
EVC icon
2567
Entravision Communication
EVC
$850M
– –
-39,800
Closed -$227K
FOR icon
2568
Forestar Group
FOR
$1.48B
– –
-16,617
Closed -$286K
FOSL icon
2569
Fossil Group
FOSL
$310M
– –
-16,316
Closed -$152K
FTEK icon
2570
Fuel Tech
FTEK
$43.7M
– –
-13,700
Closed -$14K
GIFI
2571
DELISTED
Gulf Island Fabrication
GIFI
– –
-16,238
Closed -$206K
GNL icon
2572
Global Net Lease
GNL
$1.91B
– –
-16,423
Closed -$359K
GNSS icon
2573
Genasys
GNSS
$76.1M
– –
-32,682
Closed -$70K
GOGO icon
2574
Gogo Inc
GOGO
$392M
– –
-24,968
Closed -$295K
HBIO icon
2575
Harvard Bioscience
HBIO
$27.6M
– –
-2,820
Closed -$106K
101 102
103
104 105

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.